How do you think about biologic use in patients with underlying HIV infection?   

This is always a difficult problem, and a tough clinical call. However, over the years of seeing these people, I have come to realize that following their viral load and CD4 counts while looking for immunologic recovery allows us as Rheumatologists a lot of opportunities to treat. While I have class...

I agree with Dr. @Paul J. DeMarco. I communicate with the patient ID physician. If they have well controlled HIV, then you can essentially treat them like other patients. Those with poor adherence or who choose not to take anti-retroviral therapy are another story.